These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF. Scully KJ, Brenner L, Martin K, Ruazol M, Sawicki GS, Uluer A, Neuringer I, Yonker LM, Sicilian L, Putman MS. Front Endocrinol (Lausanne); 2024 Apr; 15():1293709. PubMed ID: 38379863 [Abstract] [Full Text] [Related]
16. Relationship between exercise capacity and glucose tolerance in cystic fibrosis. Foster K, Huang G, Zhang N, Crisalli J, Chini B, Amin R, Elder D. Pediatr Pulmonol; 2018 Feb; 53(2):154-161. PubMed ID: 29115018 [Abstract] [Full Text] [Related]
17. The utility of glucose area under the curve from the oral glucose tolerance test as a screening tool for cystic fibrosis-related diabetes. Gileles-Hillel A, Soesman LH, Miari S, Breuer O, Tsabari R, Elyashar-Earon H, Armoni S, Sprikkelman AB, Reiter J, Zangen D, Lavi E, Kerem E, Cohen-Cymberknoh M. Pediatr Pulmonol; 2022 Nov; 57(11):2774-2780. PubMed ID: 35999051 [Abstract] [Full Text] [Related]